Zynex Insider-Eigentum
Was ist das Insider-Eigentum von Zynex?
Insider-Eigentum von Zynex, Inc. ist 43.38%
Was ist die Definition von Insider-Eigentum?
Das Insider-Eigentum wird berechnet als die Gesamtzahl der Aktien, die sich im Besitz von Insidern (Anteilseignern, die mehr als 5% der Gesellschaft oder eines leitenden Angestellten oder Direktors der Gesellschaft besitzen), dividiert durch die Gesamtzahl der ausstehenden Aktien.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider-Eigentum von Unternehmen in Health Care Sektor auf HKSE im Vergleich zu Zynex
Was macht Zynex?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Unternehmen mit insider-eigentum ähnlich Zynex
- TPG Pace Tech Opportunities hat Insider-Eigentum von 43.35%
- Tungtex () hat Insider-Eigentum von 43.35%
- Yellow Brick Road hat Insider-Eigentum von 43.36%
- KDA hat Insider-Eigentum von 43.37%
- Forbidden Foods hat Insider-Eigentum von 43.37%
- Investment AB Oresund (publ) hat Insider-Eigentum von 43.37%
- Zynex hat Insider-Eigentum von 43.38%
- Lemon Tree Hotels hat Insider-Eigentum von 43.39%
- Bowen Coking Coal hat Insider-Eigentum von 43.40%
- Orient Cement hat Insider-Eigentum von 43.40%
- Xtierra hat Insider-Eigentum von 43.41%
- Australian Silica Quartz hat Insider-Eigentum von 43.41%
- Intelicare hat Insider-Eigentum von 43.41%